MXCT.L实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 00:15):

Stats
今日成交量	147 633
平均成交量	27 213.00
市值	412.85M
EPS	£0 ( 2024-05-06 )
下一个收益日期	( £0 ) 2024-06-21
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-13.62
ATR14	£4.64 (1.13%)

MaxCyte Inc 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

MaxCyte Inc 财务报表

Annual	2023
营收:	£41.29M
毛利润:	£36.55M (88.51 %)
EPS:	£-0.370

FY	2023
营收:	£41.29M
毛利润:	£36.55M (88.51 %)
EPS:	£-0.370

FY	2022
营收:	£44.26M
毛利润:	£39.16M (88.48 %)
EPS:	£-0.190

FY	2021
营收:	£33.89M
毛利润:	£30.25M (89.24 %)
EPS:	£-0.210

Financial Reports:

No articles found.

MaxCyte Inc

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.